RUVAX
RUVAX
Not authorised
- Erysipelothrix rhusiopathiae, serotype 2, Inactivated
Product identification
Medicine name:
RUVAX
Active substance:
- Erysipelothrix rhusiopathiae, serotype 2, Inactivated
Target species:
-
Pig (for fattening)
-
Pig (for reproduction)
-
Turkey
-
Sheep (ewe)
Route of administration:
-
Intramuscular use
-
Subcutaneous use
Product details
Active substance and strength:
-
Erysipelothrix rhusiopathiae, serotype 2, Inactivated1.00/enzyme-linked immunosorbent assay unit2.00millilitre(s)
Pharmaceutical form:
-
Suspension for injection
Withdrawal period by route of administration:
-
Intramuscular use
- Pig (for fattening)
-
All relevant tissues0day
-
- Pig (for reproduction)
-
All relevant tissues0day
-
-
Subcutaneous use
- Turkey
-
All relevant tissues0day
-
- Pig (for reproduction)
-
All relevant tissues0day
-
All relevant tissues0day
-
- Sheep (ewe)
-
All relevant tissues0day
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QI01CB02
- QI04AB08
- QI09AB03
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Surrendered
Authorised in:
-
France
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Legal basis not covered by Directive 2001/82/EC
Marketing authorisation holder:
- Boehringer Ingelheim Animal Health France
Marketing authorisation date:
Manufacturing sites for batch release:
- Boehringer Ingelheim Animal Health France
Responsible authority:
- National Veterinary Medicines Agency
Authorisation number:
- FR/V/2390009 1/1985
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
This document does not exist in this language (English). You can find it in another language below.
French (PDF)
Published on: 4/04/2022
How useful was this page?:
